Abstract
As the COVID-19 pandemic has developed, concern for invasive fungal infections in critically ill COVID-19 patients with acute respiratory distress syndrome (ARDS) has emerged. We describe a clinical case of coronavirus disease (COVID-19) associated pulmonary aspergillus (CAPA) infection and acute respiratory distress syndrome (ARDS) with a good clinical outcome, in a previously well, non-immunocompromised Australian woman.
Original language | English |
---|---|
Pages (from-to) | 6-10 |
Number of pages | 5 |
Journal | Medical Mycology Case Reports |
Volume | 31 |
Early online date | 18 Jun 2020 |
DOIs | |
Publication status | Published - Mar 2021 |
Externally published | Yes |
Bibliographical note
Copyright the Author(s) 2020. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.Keywords
- ARDS
- COVID-19 associated pulmonary aspergillosis (CAPA)
- Fungal infection
- ICU